About the Authors

Søren Søgaard Lund

sqrl@steno.dk

Affiliation Steno Diabetes Center, Gentofte, Denmark

Lise Tarnow

Affiliation Steno Diabetes Center, Gentofte, Denmark

Anne Sofie Astrup

Affiliation Steno Diabetes Center, Gentofte, Denmark

Peter Hovind

Affiliation Steno Diabetes Center, Gentofte, Denmark

Peter Karl Jacobsen

Affiliation Steno Diabetes Center, Gentofte, Denmark

Amra Ciric Alibegovic

Affiliation Steno Diabetes Center, Gentofte, Denmark

Ida Parving

Affiliation Steno Diabetes Center, Gentofte, Denmark

Lotte Pietraszek

Affiliation Steno Diabetes Center, Gentofte, Denmark

Merete Frandsen

Affiliation Steno Diabetes Center, Gentofte, Denmark

Peter Rossing

Affiliation Steno Diabetes Center, Gentofte, Denmark

Hans-Henrik Parving

Affiliations Rigshospitalet, Department of Medical Endocrinology, University of Copenhagen, Copenhagen, Denmark, Faculty of Health Sciences, University of Aarhus, Aarhus, Denmark

Allan Arthur Vaag

Affiliations Steno Diabetes Center, Gentofte, Denmark, Department of Endocrinology, University of Lund, Malmö, Sweden

Competing Interests

Søren S. Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter K. Jacobsen, Amra Ciric Alibegovic, Ida Parving, Lotte Pietraszek, Merete Frandsen, Peter Rossing, Hans-Henrik Parving and Allan Vaag have reported equity in Novo Nordisk A/S. Lise Tarnow, Hans-Henrik Parving and Allan A. Vaag has received funds from Novo Nordisk A/S for research. Søren S. Lund and Allan A. Vaag have received fees from Novo Nordisk A/S for speaking and Allan A.Vaag has received fees from Novo Nordisk A/S for organising education. All authors are present or former employees at Steno Diabetes Center, Gentofte, Denmark. Steno Diabetes Center is an independent academic institution owned by Novo Nordisk A/S and The Novo Nordisk Foundation.

Author Contributions

Conceived and designed the experiments: SSL LT PKJ HHP AV. Performed the experiments: SSL LT ASA PH ACA IP LP MF. Analyzed the data: SSL PR AV. Wrote the paper: SSL LT ASA PH PKJ ACA IP LP MF PR HHP AV.